Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2018-07-20
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
NCT03912194
Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation
NCT02192762
Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology
NCT04172623
Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers
NCT02973425
A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers
NCT00706979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intervention group will continue to wear the wristband and the wristband will deliver a slight electric stimulus every time it is pressed.
The placebo group will wear continue to press the button on the wristband but it will not give a slight electric stimulus when pressed. Both groups will wear the device for a total of 4 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pavlok wristband with electric stimulus
Participants in intervention group will wear wristband and will get a slight electric stimulus when they press the device
Pavlok wristband with electric stimulus
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist. Device has maximum voltage of 0-500 volts, delivers a electric stimulus for a maximum of 1 sec and average duration of 0.2 secs
Pavlok wristband without electric stimulus
Participants in control group will wear wristband and will not get a slight electric stimulus when they press the device
Pavlok wristband without electric stimulus
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist. Participants will not receive any electric stimulus since this feature will be turned off.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pavlok wristband with electric stimulus
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist. Device has maximum voltage of 0-500 volts, delivers a electric stimulus for a maximum of 1 sec and average duration of 0.2 secs
Pavlok wristband without electric stimulus
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist. Participants will not receive any electric stimulus since this feature will be turned off.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Interested in quitting (contemplation stage and beyond, as defined by serious consideration of quitting smoking in the next 30 days
* Subject is equal to or greater than 19 years old
* Considers themselves "tech savvy" (based on self reported 5 point likert scale)
* Must have a smart phone with blue tooth capabilities
* Willing to receive aversive therapy if assigned to this group.
Exclusion Criteria
* Non-English speaking caregivers
* Lives outside of contiguous United States
19 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nipam Shah, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Rochford, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F23234543
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.